Cabinet has approved a process to find new technology and investor partners in the Ketlaphela project, which aims to establish a government-controlled and fully integrated pharmaceutical company, focusing on the local manufacture of antiretrovirals (ARVs).
Ketlaphela is a joint venture of Pelchem Soc Ltd (Pelchem), the only fluorochemical company in the Southern Hemisphere, and the Industrial Development Corporation of South Africa Limited (IDC) the foremost development financier in South Africa.
The process will begin with the publishing of a request for information for qualification from potential local and/or international technology and investment partners for Ketlaphela.



